Upcoming Events
Search Result For "Conjugate".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug deve...
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing compan...
With linker and conjugate deals dominating the ADC industry and more companies shifting their focus towards the chemistries behind linkers and conj...
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and m...
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and bett...
There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing ...
As the proportion of clinically site-specific ADCs increases, the abundance of novel conjugation technologies diversifies, and the linker chemistry...
The 2nd Oligonucleotides CMC and Analytical Development Summit returns this August to Boston. With the unprecedented growth of the oligonucleoti...
The ADC renaissance has continued to dominate the oncology field throughout 2023, with the long-awaited approval of ImmunoGen's ELAHERE - the 9th A...
Driving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and Form...
Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable ...
Positioned in the goldilocks spot between small molecules and biologics, peptide therapeutics have undergone an exciting uphill trajectory within t...